Democracy Dies in Darkness
Ara Darzi’s editorial on November 7 highlighted a crucial issue: the rise of bacteria that overpower antibiotics. This problem demands immediate attention from governments around the world.
The development of antibiotic-resistant bacteria presents significant risks. These microorganisms threaten to undermine healthcare advancements. If the situation goes unchecked, common medical practices like surgeries, joint replacements, and organ transplants could become highly dangerous. Chemotherapy treatments for cancer patients could also be compromised.
At a Sandoz manufacturing facility in Kundl, Austria, machinery operates to produce amoxicillin, one of the many drugs facing resistance due to bacterial adaptation.

The Future of MAHA in American Health Politics
Insulin Cost Caps Gaining Support Amid Rising Prices
Efforts to Counter Food Assistance Cutbacks in San Diego
A Personal Journey Through Encephalitis
Low-Cost Medication May Benefit Stroke Survivors
The Complex Debate Over Kratom Use in the U.S.